Investment Partners Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538K Buy
9,337
+40
+0.4% +$2.3K 0.3% 91
2026
Q1
$564K Hold
9,297
0.35% 85
2025
Q4
$501K Hold
9,297
0.31% 89
2025
Q3
$419K Sell
9,297
-200
-2% -$9.34K 0.28% 108
2025
Q2
$440K Hold
9,497
0.31% 100
2025
Q1
$579K Sell
9,497
-1
-0% -$58 0.45% 71
2024
Q4
$537K Hold
9,498
0.42% 70
2024
Q3
$491K Hold
9,498
0.4% 77
2024
Q2
$394K Sell
9,498
-51
-0.5% -$2.28K 0.35% 85
2024
Q1
$518K Sell
9,549
-1,120
-10% -$57.1K 0.47% 65
2023
Q4
$547K Buy
+10,669
New +$560K 0.54% 59

Other funds holding BMY

Investment Partners Asset Management's BMY Position: Q2 2026 in Review

Investment Partners Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.43% in Q2 2026, buying an estimated $2.3K and bringing the position to 9,337 shares worth $538K. The position accounts for 0.3% of the portfolio, ranked #91.

Investment Partners Asset Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $579K in Q1 2025. 1,045 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Investment Partners Asset Management held 9,337 shares of Bristol-Myers Squibb worth $538K as of Q2 2026.
  • Investment Partners Asset Management bought 40 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.3K.
  • Bristol-Myers Squibb made up 0.3% of Investment Partners Asset Management's portfolio in Q2 2026, its #91 holding.
  • Investment Partners Asset Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Investment Partners Asset Management's Bristol-Myers Squibb position peaked at $579K in Q1 2025.
  • 1,045 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Investment Partners Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.